Enzymotec Cognitive Products Achieve Halal Status

08 Jul 2011 --- This important certification verifies that Enzymotec, as the leading supplier of phosphatidylserine, is producing in conformity with the preparation and ingredient standards of the Halal lifestyle and that Enzymotec is permitted to display the “Crescent M Halal” logo on the products.

7/8/2011 --- Enzymotec is proud to announce that its SharpPS (phosphatidylserine) line of cognitive products used in dietary supplements is now certified by the Islamic Food and Nutrition Council of America (IFANCA) as Halal.

This important certification verifies that Enzymotec, as the leading supplier of phosphatidylserine, is producing in conformity with the preparation and ingredient standards of the Halal lifestyle and that Enzymotec is permitted to display the “Crescent M Halal” logo on the products.

IFANCA Halal certification provides an independent third party quality assurance step valued by conscientious consumers.

Phosphatidylserine (PS) is one of the most researched ingredients shown to be potent for cognitive activity. Through clinical data obtained by Enzymotec and others, PS was shown to be beneficial for cognitive functions such as concentration, focus, learning, memory and to significantly improve cognitive ability in elderly adults with memory complaints.

Phosphatidylserine is one of the body's major building blocks. It is a natural nutrient found in the cell membrane and particularly abundant in the brain. Phosphatidylserine has a crucial contribution to the structure and function of the nerve cells, and as suggested by its high abundance in the brain, has a crucial role in the maintenance of nerve cell function, such as neurotransmission of specialized chemicals, signal propagation and more.

PS is the only cognitive bioactive ingredient that has been granted with a qualified health claim by the FDA, related to cognitive dysfunction and dementia in the elderly.

Sharp PS is a high purity phosphatidylserine (PS) brand, developed and produced by Enzymotec under the highest quality and safety standards.

Being the leading supplier of PS, Enzymotec is developing and providing second generation PS products including Sharp PS Gold and Sharp PS Green.

To contact our editorial team please email us at editorial@cnsmedia.com

Enzymotec

Collapse

Who We Are

Enzymotec develops and manufactures nutritional ingredients and medical foods, driven by a deep core of cutting-edge, proprietary technologies. Since its establishment in 1998, the company has enjoyed accelerated growth, generating impressive sales worldwide, by launching a diverse portfolio of innovative products. Our two business segments leverage our lipid-related expertise: Nutrition and Pharma.

Enzymotec's diverse range of products span the entire human life-cycle - from infancy to old age, providing key ingredients for use in infant formula and nutritional supplements, as well as branded medical foods.

Enzymotec's multi-disciplinary team, including scientists, engineers and business development professionals, have an outstanding track-record in turning advanced lipid science into commercially attractive, nutritional solutions, constantly enriching our unique cluster of technology and expertise.

What We Do

We develop clinically-validated products including bio-functional, lipid-based compounds that address a wide spectrum of growing consumer demands, such as optimal development, supplementation for nutritional deficiencies and needs, and the management of medical disorders and diseases.

The comprehensive solutions we develop and manufacture are sold to major consumer companies through our global sales and marketing infrastructure.

How We Do It

We employ proprietary technologies to modify lipids harvested from natural sources, transforming these raw materials into unique and clinically-proven lipid based products. These products are familiar to the human body and possess beneficial secondary characteristics, such as extended shelf life and improved scent or taste profile.

Our Source of Competitive Advantage:

• Safe and clinically-proven products supported by proprietary technology and R&D expertise.

• Experienced leadership and scientific advisory boards.

• Diversified business model

• Strong customer relationships and partnerships

• Integrated scalable platform and product offering, based on state-of-the-art production capabilities.

Related Articles

Nutrition & Health News

Astaxanthin: AstaReal explores the science, market and potential behind red carotenoid

12 Apr 2018 --- Driven by a consumer demand for health and wellness products, astaxanthin is experiencing huge growth in the European market as well as booming demand in Asia. During a NutritionInsight webinar is entitled “Performance and Recovery: Natural Astaxanthin Opportunities,” Maryanne Mburu, Key Account Manager at AstaReal, and Dr. Mark Miller explored the product development and untapped opportunity for the health ingredient. 

Nutrition & Health News

Cognitive health: Cambridge Commodities taps into RTD functional formats 

12 Mar 2018 --- Cognitive functional foods have been growing in popularity among consumers and Cambridge Commodities believes that foods that improve brain function are set for strong growth in the coming years. The company is on a mission to reinvent nootropics, to make them more accessible for consumers to drink on the go and when they most need them. 

Nutrition & Health News

Chronic heavy drinking major risk factor for dementia: The Lancet

21 Feb 2018 --- Excessive alcohol use is a major risk factor for onset of all types of dementia, especially early-onset dementia, according to a French nationwide observational study, published in The Lancet Public Health journal. Previous research has shown mixed results regarding the effect of alcohol on cognitive health, with some studies showing a possible benefit of light to moderate drinking, while others have found detrimental effects of heavy drinking on dementia risk.

Business News

Frutarom takes full ownership of Enzymotec, sells krill oil business to Aker BioMarine

19 Jan 2018 --- Frutarom Industries has completed its acquisition of full ownership of Enzymotec. Upon completion of the transaction on January 11, 2018, Enzymotec shares were delisted from trading on NASDAQ and it ceased to be a public company. Frutarom reports that it is working towards implementing the full merger plan of all Enzymotec activities through the rapid, efficient and comprehensive integration of both companies’ activities in the areas of management, R&D, sales and marketing, production and supply chain. As part of its merger plan, Frutarom has announced the sale of Enzymotec’s krill oil business to Aker BioMarine.

Nutrition & Health News

Cognitive health: High-salt diet linked to dementia, finds mouse study

17 Jan 2018 --- Excessive consumption of salt is known to affect heart health and blood pressure, but research by scientists at Weill Cornell Medicine has now underlined its negative effect on cognitive health. According to their study, a high-salt diet reduces resting blood flow to the brain and causes dementia in mice. The study, published on Monday in Nature Neuroscience, is the first to unveil a gut-brain connection linking high dietary salt intake to neurovascular and cognitive impairment. The findings illuminate a potential future target for countering harmful effects to the brain caused by excess salt consumption.

More Articles
URL : http://www.nutritioninsight.com:80/news/Enzymotec-Cognitive-Products-Achieve-Halal-Status.html